Navigation Links
New Study Answers CMS/USPSTF Concerns for CT Colonography Screening Reimbursement: It is a Viable Option for the Medicare-Aged Population
Date:7/16/2012

STONY BROOK, N.Y., July 16, 2012 /PRNewswire/ -- Viatronix Incorporated announced today that the stage finally appears set for a reversal of the May 2009 non-coverage decision for screening CTC by The Centers for Medicare & Medicaid Services (CMS). The latest CTC study, "CT Colonography of a Medicare-Aged Population: Outcomes Observed in an Analysis of More Than 1400 Patients" (American Journal of Roentgenology, AJR2012; 199:W27-W34), provides overwhelming evidence that CT Colonography is an effective screening tool for colorectal cancer in the Medicare-aged population. The lack of Medicare-age specific data on CTC was the primary reason given for CMS' non-coverage decision.

This is the largest CTC study targeting the Medicare-aged population and not only answers the question of efficacy in this age group but addresses the significance of extra-colonic findings and risks of ionizing radiation in these patients, concerns also noted by CMS in their May 2009 decision. Additionally, two companion bills ("CT Colonography Screening for Colorectal Cancer Act of 2012") have been introduced in the Senate (S.2265) and House of Representatives (H.R.4165) to provide Medicare recipients access to CT Colonography as a screening option.  

Every year over 50,000 Americans die from colorectal cancer in the U.S. and another 150,000 new cases of colorectal cancer are diagnosed. Colorectal Cancer is more than 90% preventable through early screening, yet only 50-60% of those people recommended for screening (generally over 50 years of age) are getting screened. People tend to shy away from the traditional optical colonoscopy for their own reasons, i.e., it's invasive, requires sedation, etc… Other studies have shown patients prefer CT Colonography when offered as an alternative for screening. Collectively the authors of this study have screened over 25,000 patients using CT Colonography. 

Screening CT Colonography is currently being reimbursed by insurance carriers in approximately 30 States within the U.S.  This study adds to the mounting proof that CT Colonography should be added to the list of approved screening services to increase screening compliance and ultimately reduce the number of deaths from colon cancer.

Viatronix has been a leader in the field of CTC for over a decade and has supported research with the goal of providing patients with a low cost, less invasive and effective screening alternative. We're proud that our leading edge V3D-Colon system is helping prove the effectiveness of CTC for all recommended age groups including our over 65 population.

About Viatronix

Viatronix, located in Stony Brook, New York, U.S.A. is a leading innovator of non-invasive 2D/3D medical imaging and diagnostic software that enables physicians to interactively view vital organs and anatomical structures within the human body. The Company's V3D® technology software solutions include Viatronix V3D-Colon, V3D-Cardiac, V3D-Vascular, V3D-Calcium Scoring and V3D-Explorer.

To learn more, call us at 1-866-887-4636 or visit: www.viatronix.com.


'/>"/>
SOURCE Viatronix Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
5. Shingles Vaccine is Safe, According to New Study
6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
Breaking Medicine Technology:
(Date:4/22/2017)... ... April 22, 2017 , ... ... has named PROSHRED® Security of Philadelphia its “Woman-Owned Small Business of ... specializes in providing information destruction , recycling, and compliance services to ...
(Date:4/22/2017)... ... 2017 , ... The San Juan Capistrano summer camp team at the Boys and ... for summer camps to provide physical activities for all campers. To read the report, ... , With an increase in specialty camps that focus on what the report terms as ...
(Date:4/21/2017)... ... , ... The staff at Palm Beach Face is proud to announce that their practice founder, ... Set to take place on April 23rd, the London Marathon has a long tradition of ... part of team EMPOWER, raising money for the international charity, Smile Train. , ...
(Date:4/21/2017)... CITY, Utah (PRWEB) , ... April 21, 2017 ... ... of wilderness therapy treatment for adolescents and young adults, has kicked off its ... 20th-Sunday, April 23rd. This year’s theme is “Attachment Informed Therapy for Mental ...
(Date:4/21/2017)... ... April 21, 2017 , ... Dudnyk has announced the launch of its ... that the full potential of specialty and orphan brands can only be achieved when ... , “The Unifying Effect is at the heart of a true partnership between our ...
Breaking Medicine News(10 mins):